IFNG and asthma: The underlying mechanisms of BA in the treatment of immune modulation on PF and asthma manifest as the regulation of Th17/Treg responses by promoting Treg cell differentiation, inhibiting the expression of Th17A, and reducing the levels of IL-6, IFN-γ, IL-4, and IL-23 (Figure 3).